Cargando…
Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
Chronic liver disease (CLD) and cirrhosis accounts for approximately 2 million deaths annually worldwide. CLD and cirrhosis-related mortality has increased steadily in the United States.(1,2) With the global pandemic of coronavirus disease 2019 (COVID-19), patients with CLD and cirrhosis represent a...
Autores principales: | Kim, Donghee, Bonham, Clark Andrew, Konyn, Peter, Cholankeril, George, Ahmed, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271030/ https://www.ncbi.nlm.nih.gov/pubmed/34256143 http://dx.doi.org/10.1016/j.cgh.2021.07.009 |
Ejemplares similares
-
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
por: Kim, Donghee, et al.
Publicado: (2022) -
Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States
por: Kim, Donghee, et al.
Publicado: (2023) -
The current trends in the health burden of primary liver cancer across the globe
por: Konyn, Peter, et al.
Publicado: (2023) -
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
por: Konyn, Peter, et al.
Publicado: (2023) -
Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
por: Kim, Donghee, et al.
Publicado: (2023)